title: Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
abstract: OBJECTIVE
  To evaluate the diagnostic value of position emission tomographic (PET) imaging with F-18 fluorodeoxyglucose (FDG) in differentiating between benign and malignant breast tumors.
  
  
  METHODS
  Fifty-one patients, with suspicious breast lesions newly discovered either by physical examination or by mammography, underwent PET imaging before exploratory surgery. FDG-PET images of the breast were analyzed visually and quantitatively for objective assessment of regional tracer uptake.
  
  
  RESULTS
  Primary breast cancer was identified visually with a sensitivity of 68% to 94% and a specificity of 84% to 97% depending on criteria used for image interpretation. Quantitative analysis of FDG uptake in tumors using standardized uptake values (SUV) showed a significant difference between benign (1.4 +/- 0.5) and malignant (3.3 +/- 1.8) breast tumors (P < .01). Receiver operating characteristic (ROC) curve analysis exhibited a sensitivity of 75% and a specificity of 100% at a threshold SUV value of 2.5. Sensitivity increased to 92% with a corresponding specificity of 97% when partial volume correction of FDG uptake was performed based on independent anatomic information.
  
  
  CONCLUSIONS
  PET imaging allowed accurate differentiation between benign and malignant breast tumors providing a high specificity. Sensitivity for detection of small breast cancer ( < 1 cm) was limited due to partial volume effects. Quantitative image analysis combined with partial volume correction may be necessary to exploit fully the diagnostic accuracy. PET imaging may be helpful as a complimentary method in a subgroup of patients with indeterminate results of conventional breast imaging.
authors.affiliation: Department of Nuclear Medicine, Technische Universität München, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Avril
authors.forename: J
authors.initials: J
authors.lastname: Dose
authors.forename: F
authors.initials: F
authors.lastname: Jänicke
authors.forename: S
authors.initials: S
authors.lastname: Bense
authors.forename: S
authors.initials: S
authors.lastname: Ziegler
authors.forename: C
authors.initials: C
authors.lastname: Laubenbacher
authors.forename: W
authors.initials: W
authors.lastname: Römer
authors.forename: H
authors.initials: H
authors.lastname: Pache
authors.forename: M
authors.initials: M
authors.lastname: Herz
authors.forename: B
authors.initials: B
authors.lastname: Allgayer
authors.forename: W
authors.initials: W
authors.lastname: Nathrath
authors.forename: H
authors.initials: H
authors.lastname: Graeff
authors.forename: M
authors.initials: M
authors.lastname: Schwaiger
mesh_terms: D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D012372:ROC Curve; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed
chemical_list: D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose